Navigation Links
China Sky One Medical, Inc. Receives Scientific Achievement Award
Date:12/29/2008

HARBIN, China, Dec. 29 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), announced today that it was awarded Science and Technology Prize by Shandong Province for its Naftopidil Dispersible Tablet, a new drug developed by its wholly-owned subsidiary Peng Lai Jin Chuang Pharmaceutical Company (Jin Chuang).

Naftopidil Dispersible Tablets are intended for the treatment of enlarged prostate in men and can be easily absorbed and digested by the human body. Jin Chuang has taken five years to research and develop the Naftopidil Dispersible Tablet. Currently, the tablet can only be produced by Jin Chuang and it is expected to be launched in China early 2009.

"China Sky One Medical is honored to receive such a prestigious award which was widely recognized throughout China," said Mr. Yan-Qing Liu, Chairman and CEO of China Sky One Medical. "In China, there is a huge potential market for drugs that treat enlarged prostate in men and we forecast that the sales of Naftopidil Dispersible Tablets will help us achieve higher revenues in 2009."

About China Sky One Medical, Inc.

China Sky One Medical, Inc., a Nevada corporation, is a holding company. The Company engages in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company ("TDR"), Harbin First Bio- Engineering Company Limited ("First"), Heilongjiang Tianlong Pharmaceutical, Inc. ("Tianlong") and Peng Lai Jin Chuang Pharmaceutical Company ("Jin Chuang") the Company manufactures and distributes over-the-counter pharmaceutical products, which make up its major revenue source. For more information, visit http://www.skyonemedical.com .

Safe Harbor Statement

Certain of the statements made in the press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the use of forward- looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology. Such statements typically involve risks and uncertainties and may include financial projections or information regarding our future plans, objectives or performance. Actual results could differ materially from the expectations reflected in such forward-looking statements as a result of a variety of factors, including the risks associated with the effect of changing economic conditions in The People's Republic of China, variations in cash flow, reliance on collaborative retail partners and on new product development, variations in new product development, risks associated with rapid technological change, and the potential of introduced or undetected flaws and defects in products, and other risk factors detailed in reports filed with the Securities and Exchange Commission from time to time.

    For more information, please contact:

    Company Contact:
     China Sky One Medical, Inc.
     Mr. Yu-Bo Hao, CFO
     Tel:   +86-451-5399-4069
     Email: china_sky_one@yahoo.cn

    Investor Relations Contact:
     CCG Investor Relations
     Mr. Crocker Coulson, President
     Tel:   +1-646-213-1915
     Email: crocker.coulson@ccgir.com
     Web:  http://www.ccgirasia.com

'/>"/>
SOURCE China Sky One Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. China Medicine to Distribute Dental and Surgical Instruments
2. HUYA Bioscience Announces Agreement to Provide Schering-Plough With Drug Development Candidates From China
3. VIASPACE Plants Biofuel & Animal Feed Grass and Signs Land Lease in China
4. China Sky One Medical, Inc. Interviewed in The China Perspective
5. China Medicine Corporation Awarded GSP Certification
6. NSD Bio Group, LLC chosen by U.S.-China Economic & Security Review Commission for Report on Chinas High Tech Sectors
7. China Medical Technologies Completes the Development of EGFR Molecular Diagnostic Kits
8. China Sky One Medical, Inc. Obtains Production Rights for Nine New Drugs
9. China Biologic Products Reports Strong Third Quarter 2008 Results
10. NYSE Alternext US Accepts China Shenghuos Compliance Plan for Continued Listing
11. China Medical Technologies Receives SFDA Approval for Breast Cancer HER-2 FISH Probe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... PHOENIX and NEW YORK ... announced the near completion of their $7M Series B ... on top of the $3.5M led by Mesa Verde ... of 2016.  These resources will be directed towards further ... Test, PCDx, a comprehensive genomic profiling test and expanding ...
(Date:2/15/2017)... ... February 15, 2017 , ... Executive search firm, ... Officer with GenePeeks. Matt is a veteran life sciences and molecular diagnostics ... company focused on identifying inherited disease risk in future generations. In his new ...
(Date:2/15/2017)... FRANCISCO , 15. Februar 2017  Trianni, ... Janssen Biotech, Inc. (Janssen) eine Lizenzvereinbarung über die ... ihrer Klasse führenden Plattform für die Entdeckung monoklonaler ... durch ihr neuartiges chimäres Gensegmentdesign aus, das ... an humanen Antikörpern bietet und das für die ...
(Date:2/15/2017)... 15, 2017  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... the fourth quarter and full year ended December ... year for Vanda as we continued to demonstrate ... long-term exclusivity for Fanapt," said Mihael H. Polymeropoulos, ... emerging pipeline with important 2017 milestones underscores Vanda,s ...
Breaking Biology Technology:
(Date:1/21/2017)... Research and Markets has announced the addition of the ... ... voice recognition biometrics market to grow at a CAGR of 19.36% ... present scenario and the growth prospects of the global voice recognition ... considers the revenue generated from the sales of voice recognition biometrics ...
(Date:1/19/2017)... , Jan. 19, 2017 ... user experience and security for consumer electronics, and ... payment processing systems and cybersecurity solutions, today announced ... enterprises and financial institutions worldwide to bolster security ... the end-to-end secure user authentication platforms they offer, ...
(Date:1/18/2017)... Minn. , Jan. 18, 2017 ... technology company that supports the entire spectrum of ... has been another record-breaking year for the organization ... market interest in MedNet,s eClinical products and services. ... the tremendous marketplace success of iMedNet ...
Breaking Biology News(10 mins):